Immunology researchers uncover pathways that direct immune system to turn 'on' or 'off'

March 18, 2014 by Annie Deck-Miller, Roswell Park Cancer Institute

(Medical Xpress)—A key discovery explaining how components of the immune system determine whether to activate or to suppress the immune system, made by Kelvin Lee, MD, Professor of Oncology and Co-Leader of the Tumor Immunology and Immunotherapy Program at Roswell Park Cancer Institute (RPCI), and colleagues led to published findings being selected as the "Paper of the Week" by the Journal of Biological Chemistry (JBC). The honor places his work among the top 2 percent—in terms of significance and overall importance—of the year's manuscripts reviewed by the journal.

This research focused on the immune system's (DCs), crucial cells that initiate and regulate immune responses. For example, the dendritic cells activate T lymphocytes to fight an infection or cancer. Curiously, they are also known to suppress the immune response. Determining when DCs turn the immune response "on" or "off" is a major question in immunology.

For this project, Dr. Lee's team explored two receptors (called CD80 and CD86) expressed on the surface of dendritic cells that trigger the cells to make either immune-stimulating factors (interleukin-6) or immune-suppressive factors (indolemine 2, 3 dioxygenase, IDO). They defined the intracellular pathways by which the receptors triggered each response and also uncovered a previously unrecognized interaction with another receptor called Notch-1.

Understanding how these pathways are put together opens the door to targeting components of the pathway so physicians can manipulate the dendritic cells to either activate or suppress the immune system in a way that's therapeutically beneficial.

"Activating the immune response would enhance a patient's response to a vaccine designed to prevent a cancer from growing or recurring," explains Dr. Lee. "Suppressing or blocking an unwanted would be helpful in organ-transplant cases, to prevent rejection, or in autoimmune diseases like lupus and rheumatoid arthritis."

With regard to cancer, Dr. Lee explains how manipulating the CD80/CD86 pathway could impact treatment for , a cancer of a type of white blood cell in the bone marrow.

"Myeloma cells use this pathway to survive and grow by inducing the DC to make IL-6—which promotes the ' survival—and IDO, which blocks anti-cancer responses," he says. "Targeting this pathway would be a novel treatment strategy for multiple myeloma."

The paper was published March 14, 2014, in JBC and is available online at jbc.org.

Explore further: Cancer vaccine could use immune system to fight tumors

Related Stories

Cancer vaccine could use immune system to fight tumors

February 27, 2014
Cincinnati Cancer Center (CCC) and UC Cancer Institute researchers have found that a vaccine, targeting tumors that produce a certain protein and receptor responsible for communication between cells and the body's immune ...

Novel cancer vaccine holds promise against ovarian cancer, mesothelioma

March 5, 2014
A novel approach to cancer immunotherapy – strategies designed to induce the immune system to attack cancer cells – may provide a new and cost-effective weapon against some of the most deadly tumors, including ovarian ...

What makes the newborn immune system in the lungs different and vulnerable?

February 13, 2014
Newborns are more susceptible to infections, presumably because of their immature and inexperienced immune systems. The most common dangerous condition in newborns and infants are lower respiratory tract infections caused ...

Bacteria may assist the immune system response against cancer

March 3, 2014
(Medical Xpress)—Recent research from the University of Otago shows that bacteria may assist the body's immune system response against cancer cells and help fight tumours like melanoma.

Discovery brings cancer immune therapies a step closer

February 5, 2014
(Medical Xpress)—The development of new therapies to enhance the body's immune response to cancer is much closer after University of Otago scientists identified a pathway that alters the immune response in the spleen and ...

Recommended for you

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.

Immunosuppressive cells in newborns play important role in controlling inflammation in early life

January 15, 2018
New research led by The Wistar Institute, in collaboration with Sun Yat-sen University in China, has characterized the transitory presence of myeloid-derived suppressor cells (MDSCs) in mouse and human newborns, revealing ...

Memory loss from West Nile virus may be preventable

January 15, 2018
More than 10,000 people in the United States are living with memory loss and other persistent neurological problems that occur after West Nile virus infects the brain.

Mould discovery in lungs paves way for helping hard to treat asthma

January 15, 2018
A team at The University of Manchester have found that in a minority of patients they studied, a standard treatment for asthma—oral steroids—was associated with increased levels of the treatable mould Aspergillus in the ...

Fast food makes the immune system more aggressive in the long term

January 12, 2018
The immune system reacts similarly to a high fat and high calorie diet as to a bacterial infection. This is shown by a recent study led by the University of Bonn. Particularly disturbing: Unhealthy food seems to make the ...

Past exposures shape immune response in pediatric acute respiratory infections

January 12, 2018
Acute respiratory tract infections (ARTI) are the leading global cause of death in early childhood, according to the Centers for Disease Control and Prevention (CDC). Lower respiratory tract infections, including bronchiolitis ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.